Loomis, Sayles & Company’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Buy
304,758
+59,944
+24% +$3.25M 0.02% 298
2026
Q1
$13.7M Buy
244,814
+2,809
+1% +$161K 0.02% 299
2025
Q4
$13.1M Buy
242,005
+10,616
+5% +$542K 0.02% 311
2025
Q3
$11.2M Buy
231,389
+56,300
+32% +$2.87M 0.01% 337
2025
Q2
$8.68M Buy
+175,089
New +$8.83M 0.01% 391

Other funds holding AMRZ

Loomis, Sayles & Company's AMRZ Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Amrize Ltd (AMRZ) stake by 24% in Q2 2026, buying an estimated $3.25M and bringing the position to 304,758 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #298.

Loomis, Sayles & Company first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. 463 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

  • Loomis, Sayles & Company held 304,758 shares of Amrize Ltd worth $16.2M as of Q2 2026.
  • Loomis, Sayles & Company bought 59,944 Amrize Ltd shares in Q2 2026, an estimated $3.25M.
  • Amrize Ltd made up 0.02% of Loomis, Sayles & Company's portfolio in Q2 2026, its #298 holding.
  • Loomis, Sayles & Company first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
  • 463 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.